Zobrazeno 1 - 10 of 10 pro vyhledávání: '"Teri Suzanne Krebs"'
3
Psychedelics not linked to mental health problems or suicidal behavior: a population study
Autor: Teri Suzanne Krebs, Pål-Ørjan Johansen
Publikováno v: Journal of psychopharmacology (Oxford, England). 29(3)
A recent large population study of 130,000 adults in the United States failed to find evidence for a link between psychedelic use (lysergic acid diethylamide, psilocybin or mescaline) and mental health problems. Using a new data set consisting of 135
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::022961ada0000e5818fdcac016bd9ac5
https://pubmed.ncbi.nlm.nih.gov/26649373
Zobrazit plný text záznamu
5
How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale
Autor: Teri Suzanne Krebs, Pål-Ørjan Johansen
Publikováno v: Journal of Psychopharmacology. 23:389-391
Abstract Exposure therapy is known to be an effective treatment for anxiety disorders. Nevertheless, exposure is not used as much as it should be, and instead patients are often given supportive medications such as serotonin reuptake inhibitors (SSRI
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1ee9392af2dd43fb42cacad28c463c
https://doi.org/10.1177/0269881109102787
Zobrazit plný text záznamu
6
Psychedelics and Mental Health: A Population Study
Autor: Pål-Ørjan Johansen, Teri Suzanne Krebs
Publikováno v: PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e63972 (2013)
PLOS ONE
Background The classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelic
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c33788899b843419bb6da0ee23f1c7
http://europepmc.org/articles/PMC3747247
Zobrazit plný text záznamu
7
Over 30 million psychedelic users in the United States
Autor: Pål-Ørjan Johansen, Teri Suzanne Krebs
Publikováno v: F1000Research
We estimated lifetime prevalence of psychedelic use (lysergic acid diethylamide (LSD), psilocybin (magic mushrooms), mescaline, and peyote) by age category using data from a 2010 US population survey of 57,873 individuals aged 12 years and older. The
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02db0ce6235cd38b7c73994c41f9a671
https://pubmed.ncbi.nlm.nih.gov/24627778
Zobrazit plný text záznamu
8
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Autor: Teri Suzanne Krebs, Pål Ørjan Johansen
Publikováno v: Journal of psychopharmacology (Oxford, England). 26(7)
Assessments of lysergic acid diethylamide (LSD) in the treatment of alcoholism have not been based on quantitative meta-analysis. Hence, we performed a meta-analysis of randomized controlled trials in order to evaluate the clinical efficacy of LSD in
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02d9472ab0f05ad1d5caa4b1b076dd31
https://pubmed.ncbi.nlm.nih.gov/22406913
Zobrazit plný text záznamu
9
Change in defense mechanisms during short-term dynamic and cognitive therapy in patients with cluster C personality disorders
Autor: Pål-Ørjan Johansen, Martin Svartberg, Tore C. Stiles, Teri Suzanne Krebs, Are Holen
Publikováno v: The Journal of nervous and mental disease. 199(9)
The aims of this study were to examine whether a change in overall defensive functioning during treatment a) would predict change in symptom distress during the course of treatment and follow-up and b) would be greater in short-term dynamic therapy t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97389504a243d2963e10fb76266dad89
https://pubmed.ncbi.nlm.nih.gov/21878788
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje